TP53 and breast cancer: • High UGDH expression associated with worse patient survival• UGDH KD decreased migratory and metastatic phenotype of BC cells in vitro and in vivo• High UGDH a/w TP53 mutations and copy number alterations in BRCA1 and PIK3CA